Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMC 1877622)

Published in Am J Pathol on August 01, 1990

Authors

P Cras1, M Kawai, S Siedlak, P Mulvihill, P Gambetti, D Lowery, P Gonzalez-DeWhitt, B Greenberg, G Perry

Author Affiliations

1: Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106.

Articles citing this

A three-dimensional human neural cell culture model of Alzheimer's disease. Nature (2014) 3.48

Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am J Pathol (1999) 2.10

Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A (1991) 1.41

The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol (1990) 1.40

Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation (2008) 1.29

Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease. Am J Pathol (1992) 1.20

Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases. Front Cell Neurosci (2015) 1.07

Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. Am J Pathol (1993) 1.07

Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int J Alzheimers Dis (2010) 1.05

Microglia demonstrate age-dependent interaction with amyloid-β fibrils. J Alzheimers Dis (2011) 1.01

Molecular features of hypothalamic plaques in Alzheimer's disease. Am J Pathol (1991) 1.00

Inhibition of Src kinase activity attenuates amyloid associated microgliosis in a murine model of Alzheimer's disease. J Neuroinflammation (2012) 0.98

Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy. Am J Pathol (1995) 0.97

Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease. Am J Pathol (1993) 0.97

Ultrastructural localization of Alzheimer amyloid beta/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes. Acta Neuropathol (1992) 0.97

Amyloid-β oligomers stimulate microglia through a tyrosine kinase dependent mechanism. Neurobiol Aging (2011) 0.91

Subcellular localization of amyloid precursor protein in senile plaques of Alzheimer's disease. Am J Pathol (1992) 0.88

Microglial cells and amyloid beta protein (A beta) deposition; association with A beta 40-containing plaques. Acta Neuropathol (1995) 0.87

Tissue factor antigen in senile plaques of Alzheimer's disease. Am J Pathol (1991) 0.87

Amyloidosis in aging and Alzheimer's disease. Am J Pathol (1992) 0.86

Image analysis microspectroscopy shows that neurons participate in the genesis of a subset of early primitive (diffuse) senile plaques. Am J Pathol (1991) 0.85

White matter amyloid in Alzheimer's disease brain. Acta Neuropathol (1995) 0.84

A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques. Acta Neuropathol (1995) 0.83

Alzheimer's disease. Beta-amyloid precursor protein expression in the nucleus basalis of Meynert. Am J Pathol (1992) 0.81

Alzheimer's amyloid precursor protein-positive degenerative neurites exist even within kuru plaques not specific to Alzheimer's disease. Am J Pathol (1991) 0.81

Expression and distribution of amyloid precursor protein-like protein-2 in Alzheimer's disease and in normal brain. Am J Pathol (1996) 0.81

Mitochondria are related to synaptic pathology in Alzheimer's disease. Int J Alzheimers Dis (2011) 0.80

Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression. Biochem Biophys Res Commun (2016) 0.77

Characterization of Novel Src Family Kinase Inhibitors to Attenuate Microgliosis. PLoS One (2015) 0.76

Chronic Noise Exposure Acts Cumulatively to Exacerbate Alzheimer's Disease-Like Amyloid-β Pathology and Neuroinflammation in the Rat Hippocampus. Sci Rep (2015) 0.76

Articles cited by this

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature (1987) 17.08

Diagnosis of Alzheimer's disease. Arch Neurol (1985) 12.77

Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science (1987) 8.29

A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature (1988) 5.11

A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining. Acta Neuropathol (1988) 4.10

Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature (1988) 3.99

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol (1989) 3.58

Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci U S A (1990) 3.13

Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. Science (1987) 3.07

Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. Proc Natl Acad Sci U S A (1988) 2.95

Neurofibrillary degeneration and neuronal loss in Alzheimer's disease. Neurobiol Aging (1990) 1.99

The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature (1989) 1.94

Production and characterization of monoclonal antibodies recognizing the alpha-chain subunits of human ia alloantigens. Immunology (1983) 1.85

Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can J Neurol Sci (1989) 1.84

Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron (1989) 1.59

Immunocytochemical localization of the precursor protein for beta-amyloid in the rat central nervous system. Neuron (1988) 1.40

The immunohistochemical demonstration of subsequences of the precursor of the amyloid A4 protein in senile plaques in Alzheimer's disease. Neuropathol Appl Neurobiol (1989) 1.36

Amyloid precursor protein in senile plaques of Alzheimer disease. Lancet (1988) 1.33

Monoclonal antibodies to a synthetic peptide homologous with the first 28 amino acids of Alzheimer's disease beta-protein recognize amyloid and diverse glial and neuronal cell types in the central nervous system. Am J Pathol (1989) 1.24

Cellular localization of messenger RNA encoding amyloid-beta-protein in normal tissue and in Alzheimer disease. Alzheimer Dis Assoc Disord (1988) 1.18

Early senile plaques in Down's syndrome brains show a close relationship with cell bodies of neurons. Neuropathol Appl Neurobiol (1990) 1.15

Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease. Neurobiol Aging (1989) 1.12

Soluble derivatives of the beta amyloid protein precursor of Alzheimer's disease are labeled by antisera to the beta amyloid protein. Biochem Biophys Res Commun (1989) 1.01

Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance. Lab Invest (1989) 0.90

Articles by these authors

Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98

Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science (1996) 6.71

Complementary specificity of restriction endonucleases of Diplococcus pneumoniae with respect to DNA methylation. J Mol Biol (1977) 6.55

A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature (1988) 5.11

Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res (1996) 4.89

Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol (2001) 4.80

The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology (2008) 4.78

Mitochondrial abnormalities in Alzheimer's disease. J Neurosci (2001) 4.39

Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol (1996) 4.10

A deoxyribonuclease of Diplococcus pneumoniae specific for methylated DNA. J Biol Chem (1975) 3.90

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes (2001) 3.83

Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiol Aging (2001) 3.48

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A (1997) 3.47

Identification and analysis of genes for tetracycline resistance and replication functions in the broad-host-range plasmid pLS1. J Mol Biol (1986) 3.47

The family health worker. Am J Public Health Nations Health (1968) 3.34

Sinusoidal analysis: a high resolution method for correlating biochemical reactions with physiological processes in activated skeletal muscles of rabbit, frog and crayfish. J Muscle Res Cell Motil (1980) 3.33

Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem (1995) 3.20

Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci (1997) 3.08

Identification of base mismatches recognized by the heteroduplex-DNA-repair system of Streptococcus pneumoniae. Cell (1982) 3.06

Evolutionary motif and its biological and structural significance. J Mol Evol (1997) 3.03

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol (2000) 2.99

Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc Natl Acad Sci U S A (1987) 2.97

RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci (1999) 2.86

Paired helical filaments from Alzheimer disease patients contain cytoskeletal components. Proc Natl Acad Sci U S A (1985) 2.86

4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem (1997) 2.80

Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80

Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat Med (1996) 2.71

Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. Neurology (2002) 2.66

Effect of cross-bridge kinetics on apparent Ca2+ sensitivity. J Gen Physiol (1982) 2.59

Uterine sutures at prior caesarean section and placenta accreta in subsequent pregnancy: a case-control study. BJOG (2014) 2.56

Oxidative damage in Alzheimer's. Nature (1996) 2.55

Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46

Evaluation of a clinical medical librarian program at the Yale Medical Library. Bull Med Libr Assoc (1978) 2.41

Optical diffraction studies of muscle fibers. Biophys J (1973) 2.40

Ethnic differences in pain tolerance: clinical implications in a chronic pain population. Psychosom Med (2001) 2.35

An extended -10 promoter alone directs transcription of the DpnII operon of Streptococcus pneumoniae. J Mol Biol (1995) 2.32

Radical AGEing in Alzheimer's disease. Trends Neurosci (1995) 2.32

Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol (1999) 2.31

Role of a deoxyribonuclease in the genetic transformation of Diplococcus pneumoniae. Proc Natl Acad Sci U S A (1974) 2.27

Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms. Cancer (1980) 2.26

Identification of a deoxyribonuclease implicated in genetic transformation of Diplococcus pneumoniae. J Bacteriol (1975) 2.20

Metabolism of the "Swedish" amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the "beta-secretase" site occurs in the golgi apparatus. J Biol Chem (1996) 2.19

Nucleotide sequence of the Dpn II DNA methylase gene of Streptococcus pneumoniae and its relationship to the dam gene of Escherichia coli. Proc Natl Acad Sci U S A (1985) 2.19

Two rigor states in skinned crayfish single muscle fibers. J Gen Physiol (1976) 2.15

The effect of inorganic phosphate on the ATP hydrolysis rate and the tension transients in chemically skinned rabbit psoas fibers. Pflugers Arch (1987) 2.15

Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain (2001) 2.14

Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science (1992) 2.12

Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet (1998) 2.12

Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme. J Bacteriol (1987) 2.11

Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J Cell Biol (2000) 2.11

Kinetic and thermodynamic studies of the cross-bridge cycle in rabbit psoas muscle fibers. Biophys J (1994) 2.10

Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet (2000) 2.08

The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition. Ann Neurol (1989) 2.07

Competence for deoxyribonucleic acid uptake and deoxyribonuclease action external to cells in the genetic transformation of Diplococcus pneumoniae. J Bacteriol (1973) 2.06

Nucleotide sequence of the hexA gene for DNA mismatch repair in Streptococcus pneumoniae and homology of hexA to mutS of Escherichia coli and Salmonella typhimurium. J Bacteriol (1988) 2.05

Ubiquitin is associated with abnormal cytoplasmic filaments characteristic of neurodegenerative diseases. Proc Natl Acad Sci U S A (1988) 2.04

Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (2003) 2.03

A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol (1999) 1.98

Presenilin-1 mutations in Alzheimer's disease. Nature (2000) 1.97

Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci U S A (1994) 1.91

Prepregnancy body mass index and pregnancy weight gain: associations with preterm delivery. The NMIHS Collaborative Study Group. Obstet Gynecol (2000) 1.91

pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231). J Biol Chem (1997) 1.85

Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A (1998) 1.85

Oxidative stress in Alzheimer's disease. Biochim Biophys Acta (2000) 1.84

Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem (1999) 1.83

Genetic basis of the complementary DpnI and DpnII restriction systems of S. pneumoniae: an intercellular cassette mechanism. Cell (1986) 1.83

Typing prion isoforms. Nature (1997) 1.82

Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80

Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol (1980) 1.78

Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med (1986) 1.73

Can the binding of Ca2+ to two regulatory sites on troponin C determine the steep pCa/tension relationship of skeletal muscle? Proc Natl Acad Sci U S A (1980) 1.73

Neurofibrillary changes in human brain. An immunocytochemical study with a neurofilament antiserum. J Neuropathol Exp Neurol (1983) 1.72

The exoA gene of Streptococcus pneumoniae and its product, a DNA exonuclease with apurinic endonuclease activity. J Bacteriol (1989) 1.71

Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat Med (1995) 1.69

GTP-binding protein involvement in membrane currents evoked by carbachol and histamine in guinea-pig ileal muscle. J Physiol (1992) 1.69

Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem (2001) 1.68

Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers. Annu Rev Nutr (1992) 1.68

Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem (1998) 1.68

Association between Fc epsilon RI beta and atopic disorder in a Japanese population. Lancet (1996) 1.67

Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem (2001) 1.64

The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J (1979) 1.63

Deoxyribonucleases of Pneumococcus. J Biol Chem (1967) 1.62

Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol (1994) 1.62

Absence of protease-resistant prion protein in the cerebrospinal fluid of Creutzfeldt-Jakob disease. J Pathol (2001) 1.61

In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem (2000) 1.60

Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci (2007) 1.59

Bodian's silver method stains neurofilament polypeptides. Science (1981) 1.59

MEDLINE demand profiles: an analysis of requests for clinical and research information. Bull Med Libr Assoc (1977) 1.59

Association between genetic variants of mast-cell chymase and eczema. Lancet (1996) 1.57

The effect of the lattice spacing change on cross-bridge kinetics in chemically skinned rabbit psoas muscle fibers. II. Elementary steps affected by the spacing change. Biophys J (1993) 1.56

Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene. Brain Pathol (1998) 1.56

Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol (1992) 1.55

Cloning and sequence analysis of the cDNA for the rat atrial natriuretic factor precursor. Nature (1984) 1.54

Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system. J Neurosci (1993) 1.54